Sky View Investment Advisors, LLC Global Blood Therapeutics, Inc. Transaction History

Sky View Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	SELL	$32.4 - $68.18 $1,231 - $2,590	-38 Reduced 4.73%	766 $52,000
Q1 2022 May 17, 2022	BUY	$25.68 - $35.59 $17,642 - $24,450	687 Added 587.18%	804 $28,000
Q4 2021 Feb 18, 2022	BUY	$24.9 - $40.26 $2,913 - $4,710	117 New	117 $26,000
Q3 2021 Nov 16, 2021	SELL	$25.48 - $37.34 $8,026 - $11,762	-315 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$38.94 - $50.85 $10,552 - $13,780	271 Added 615.91%	315 $13,000
Q4 2020 Mar 02, 2021	BUY	$37.65 - $63.77 $1,656 - $2,805	44 New	44 $2,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.